.The Concept
·The Glove
·Claims
·Action
·Description
·Advices
. BEAs
· Who are concerned?
· BEAs Protection
· Allergies
. Our policy
· PI Test
· MMSE Test
. CE Mark
· Standards
· Q.A.
· Manufacturing
· Control
· Hutchinson Santé
·Hutchinson Worldwide

 
 
   
   
HOME SITE MAP

R&D> G-VIR® reduces the viral load in the event of percutaneous injury




In order to evaluate G-VIR®'s disinfectant activity, we have developed specific evaluation protocols with the ever-present goal of simulating as closely as possible the actual operating conditions which correspond to documented cases of Blood Exposure Accidents .

These experimental protocols model the most common conditions of percutaneous injuries with hollow needles:

•  the volume of blood transferred via a standard diameter needle to the glove's wearer, i.e. a range from 0.05 to 1µl.

•  if the blood is contaminated, the number of viral particles transmitted to the wearer, i.e. a range from 1 to 1000 - sufficient to cause an infection.

•  very short disinfectant agent-virus contact

The protocols developed enabled us to measure precisely small numbers of viral particles (from just a few up to several hundreds) and to follow the action of the disinfectant agent, even for very short contact times.

The G-VIR® glove's performance levels have been validated by experts via protocols presented in a set of publications .

   

© 2004, HUTCHINSON Worldwide®. All Rights Reserved.


G-VIR®
Current events
Scientific Publications
Clinical data
Business operation

New !

G-VIR®Exam

For further information

Contact us

FAQ

Read them !
Useful links

References